Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  American Journal of Pathology

• Publication date

  1989-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2556929PMCID PMC1880481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of type 1 insulinlike growth factor (IGF) receptors in Wilms' tumors.

  1988cited by this paper
• Growth characteristics of human Wilms' tumor in nude mice.

  1988cited by this paper
• Insulin-like growth factor II receptor as a multifunctional binding protein

  1987cited by this paper
• The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor.

  1987cited by this paper
• Polypeptide growth factors: roles in normal and abnormal cell growth.

  1987cited by this paper
• IGF-2 stimulated growth mediated by the somatomedin type 2 receptor.

  1987cited by this paper
• The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts.

  1987cited by this paper
• Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level.

  1987cited by this paper
• Growth factors and cancer.

  1986cited by this paper
• Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts.

  1986cited by this paper
• Expression of insulin-like growth factor-II transcripts in Wilms' tumour

  1985cited by this paper
• Evidence from monoclonal antibody studies that insulin stimulates deoxyribonucleic acid synthesis through the type I somatomedin receptor.

  1985cited by this paper
• Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues

  1985cited by this paper
• The type II insulin-like growth factor receptor does not mediate increased DNA synthesis in H-35 hepatoma cells.

  1984cited by this paper
• Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center.

  1983cited by this paper
• Monoclonal antibodies to receptors for insulin and somatomedin-C.

  1983cited by this paper

• The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins

  2015cites this paper
• Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group

  2014cites this paper
• Molecular-Targeted Therapy for Pediatric Renal Tumors

  2014cites this paper
• Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer

  2013cites this paper
• Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.

  2012cites this paper
• Molecular Targeted Therapy for Wilms’ Tumor

  2010cites this paper
• Regulation of insulin-like growth factor I receptor gene expression by the wilms’ tumor supressor WT1

  2007cites this paper
• ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents.

  2007cites this paper
• An overview of currently available anti-insulin-like growth factor I receptor antibodies.

  2007cites this paper
• SUMO and ubiquitin : The Yin and Yang of IGF-1R function

  2007cites this paper
• Inhibition of the IGF-I receptor for treatment of cancer. Kinase inhibitors and monoclonal antibodies as alternative approaches.

  2007cites this paper
• Human Fetal Kidney and Wilms ' Tumor Insulin-like Growth Factor II and WT 1 Transcript Localization in Updated Version

  2006cites this paper
• Insulin-Like Growth Factor (IGF) family and prostate cancer.

  2006cites this paper
• Effects of Insulin-like Growth Factor Receptor Inhibition on Human Melanomas in Culture and in Athymie Mice1

  2006influential citation
• Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.

  2006cites this paper
• Effects of Insulin-like Growth Factor Receptor Inhibition on Human Melanomas in Culture and in Athymie Mice 1

  2006cites this paper
• Other Human Carcinomas Factors : Increased Midkine Expression in Wilms ' Tumor and A New Family of Heparin-binding Growth / Differentiation

  2006cites this paper
• Control Regulat of lnsulin-L ion of IGF-l ike Growth Receptor Ex Factor ( IGF ) Action by pression

  2006cites this paper
• Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871

  2005cites this paper
• IGF-I and IGF-II expression in human breast cancer xenografts: Relationship to hormone independence

  2005cites this paper
• Prognostic markers in nephroblastoma (Wilms' tumor).

  2005cites this paper
• Insulin-like growth factor-I and breast cancer therapy.

  2005cites this paper
• Growth Hormone, Insulin-Like Growth Factor-1, and the Biology of Aging

  2005cites this paper
• Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibody

  2005cites this paper
• Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling

  2005cites this paper
• Influence of IGF-IR stimulation or blockade on proliferation of human renal cell carcinoma cell lines.

  2004cites this paper
• Growth Inhibition of Human Prostate Cancer Cells in Human Adult Bone Implanted into Nonobese Diabetic/Severe Combined Immunodeficient Mice by a Ligand-Specific Antibody to Human Insulin-Like Growth Factors

  2004cites this paper
• The IGFI receptor gene: A molecular target for disrupted transcription factors

  2003cites this paper
• Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 A resolution.

  2003cites this paper
• WT1-p53 Interactions in Insulin-like Growth Factor-I Receptor Gene Regulation*

  2003cites this paper
• Development of New Insulin-like Growth Factor-1 Receptor Kinase Inhibitors Using Catechol Mimics*

  2003cites this paper
• Inhibition of the Biologic Response to Insulin-like Growth Factor I in MCF-7 Breast Cancer Cells by a New Monoclonal Antibody to the Insulin-like Growth Factor-I Receptor. The Importance of Receptor Down-regulation

  2003cites this paper
• Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.

  2002cites this paper
• Cancer Growth and Metastasis Circulating Insulin-like Growth Factor-I Levels Regulate Colon

  2002cites this paper
• Crystal Structure of the Apo, Unactivated Insulin-like Growth Factor-1 Receptor Kinase

  2002cites this paper
• A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan.

  2002cites this paper
• Neutralizing anti-insulin-like growth factor receptor 1 antibodies inhibit receptor function and induce receptor degradation in tumor cells.

  2002cites this paper
• Models of growth hormone and IGF-1 deficiency: applications to studies of aging processes and life-span determination.

  2002cites this paper
• Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation.

  2001cites this paper
• Are the insulin-like growth factors relevant to cancer?

  2001cites this paper
• Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein.

  2001cites this paper
• The role of the insulin‐like growth factor system in adrenocortical tumourigenesis

  2000cites this paper
• Substrate competitive inhibitors of IGF-1 receptor kinase.

  2000cites this paper
• The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma cell lines and xenograft models

  2000cites this paper
• Hormontherapie des postoperativ rezidivierten Pankreascarcinoms mit Octreotid und Tamoxifen

  1999cites this paper
• [Hormone therapy of postoperative recurrent pancreatic carcinoma with octreotide and tamoxifen].

  1999cites this paper
• Loss of heterozygosity of the Wilms' tumor suppressor gene (WT1) in in situ and invasive breast carcinoma.

  1999cites this paper
• Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric-restricted animals.

  1999cites this paper
• The Insulin-Like Growth Factor Network and Breast Cancer

  1999cites this paper
• Genomic imprinting and carcinogenesis.

  1998cites this paper
• Replacement of Tyrosine 1251 in the Carboxyl Terminus of the Insulin-like Growth Factor-I Receptor Disrupts the Actin Cytoskeleton and Inhibits Proliferation and Anchorage-independent Growth*

  1998cites this paper
• Molecular Mechanisms of Insulin‐like Growth Factor I Receptor Function: Implications for Normal Physiology and Pathological States

  1998cites this paper
• The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis.

  1997cites this paper
• Relevance of proto-oncogenes as growth modulators in organogenesis of the mammalian embryonic kidney.

  1997cites this paper
• Progress of fundamental research in Wilms' tumor

  1997cites this paper
• Role of the IGF-I receptor in mutagenesis and tumor promotion.

  1997cites this paper
• Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells.

  1997cites this paper
• Diverse aspects of metanephric development

  1997cites this paper
• Interferon-alpha and gemcitabine (2',2'-difluorodeoxycytidine) in adult and pediatric renal tumors.

  1997cites this paper
• Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands.

  1997cites this paper
• Insulin-like growth factors and cytokines in pediatric cancer

  1997cites this paper
• Role of extracellular matrix, growth factors and proto-oncogenes in metanephric development.

  1997cites this paper
• The role of the insulin-like growth factor system in human cancer.

  1996cites this paper
• Serum levels of insulin-like growth factor-I,-II and insulin-like growth factor binding proteins-2 and-3 in children with acute lymphoblastic leukaemia

  1996cites this paper
• All-trans-retinoic acid-induced growth suppression of blastemal Wilms' tumor.

  1996cites this paper
• The WT1 Wilms' tumor suppressor gene: how much do we really know?

  1996cites this paper
• Two primitive neuroectodermal tumor cell lines require an activated insulin-like growth factor I receptor for growth in vitro.

  1996cites this paper
• Autocrine Regulation of Growth by Insulin-Like Growth Factor (IGF)-II Mediated by Type I IGF-Receptor in Wilms Tumor Cells

  1996cites this paper
• Insulin-like growth factor receptors and binding proteins.

  1996cites this paper
• Regulation of nov by WT1: a potential role for nov in nephrogenesis.

  1996cites this paper
• Control of insulin-like growth factor (IGF) action by regulation of IGF-I receptor expression.

  1996cites this paper
• Inhibition of insulin like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo.

  1996cites this paper
• Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.

  1996cites this paper
• Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1).

  1996cites this paper
• Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.

  1996cites this paper
• Insulin-like Growth Factors and Cancer

  1995cites this paper
• Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma.

  1995cites this paper
• Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin-like growth factor I receptor cDNA.

  1995cites this paper
• Serumkonzentrationen der insulinähnlichen Wachstumsfaktoren (IGF)-I und IGF-II sowie der IGF Bindungsproteine (IGFBP)-2 und IGFBP-3 bei 49 Kindern mit ALL, NHL oder soliden Tumoren

  1995cites this paper
• IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood

  1995cites this paper
• Growth factors in renal development.

  1995cites this paper
• [Serum concentrations of insulin-like growth factors (IGF)-I and IGF-II and IGF binding proteins (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors].

  1995cites this paper
• Cellular mechanisms of tubule hypertrophy and hyperplasia in renal injury.

  1995cites this paper
• Molecular and cellular aspects of the insulin-like growth factor I receptor.

  1995cites this paper
• The regulation of IGF-I receptor gene expression.

  1995cites this paper
• Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid.

  1995cites this paper
• Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression

  1995cites this paper
• Molecular and cellular aspects of insulin-like growth factor action.

  1994cites this paper
• Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.

  1994cites this paper
• Blockade of the insulin‐like growth‐factor‐I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF‐II‐mediated autocrine loop

  1994cites this paper
• Structural analysis of the human nov proto-oncogene and expression in Wilms tumor.

  1994cites this paper
• Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.

  1994cites this paper
• Human colon carcinoma cells (CaCo-2) synthesize IGF-II and express IGF-I receptors and IGF-II/M6P receptors.

  1994cites this paper
• Gene therapy of rat brain glioblastoma by an episome-based transcriptional cassette expressing antisense IGF-I cDNA.

  1994cites this paper
• The 5'-untranslated region of the IGF-I receptor gene modulates reporter gene expression by both pre- and post-transcriptional mechanisms.

  1994cites this paper
• Expression of insulin-like growth factor binding protein 2 (IGFBP-2) in Wilms' tumors.

  1994cites this paper
• Evolutionary comparison in the vertebrate lineage of WT1, a Wilms' tumour predisposition gene

  1994cites this paper
• Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors.

  1994cites this paper
• Human osteosarcoma (U‐2 OS) cells express both insulin‐like growth factor‐I (IGF‐I) receptors and insulin‐like growth factor‐II/mannose‐6‐phosphate (IGF‐II/M6P) receptors and synthesize IGF‐II: Autocrine growth stimulation by IGF‐II via the IGF‐I receptor

  1994cites this paper
• Role of growth factors in regulation of renal growth.

  1993cites this paper